Signature Equity Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
Signature Equity Partners's LH Position: Q2 2026 in Review
Signature Equity Partners increased its Labcorp (LH) stake by 63% in Q2 2026, buying an estimated $2.63K and bringing the position to 26 shares worth $7.3K. The position accounts for ﹤0.01% of the portfolio, ranked #906.
Signature Equity Partners first reported a position in LH in Q4 2025 and has held it in 3 quarters since. 1,054 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Signature Equity Partners held 26 shares of Labcorp worth $7.3K as of Q2 2026.
- Signature Equity Partners bought 10 Labcorp shares in Q2 2026, an estimated $2.63K.
- Labcorp made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #906 holding.
- Signature Equity Partners first reported a position in Labcorp in Q4 2025 and has held it in 3 quarters since.
- 1,054 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.